BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7460417)

  • 1. [Lymphocytotoxic antibodies in myasthenia gravis (author's transl)].
    Mine M; Eguchi K; Tsujihata M; Fukuda T; Takamori M
    Rinsho Shinkeigaku; 1980 Oct; 20(10):825-30. PubMed ID: 7460417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thymic lymphocyte subpopulations and myasthenia gravis (author's transl)].
    Shirai T; Kobayashi S; Ninomura N; Itoh T; Miyata M; Takami T; Kikuchi K; Sakiyama Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Sep; 16(9):672-7. PubMed ID: 723042
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
    Cojocaru IM; Cojocaru M; Muşuroi C
    Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of plasma exchange in management of myasthenia gravis (author's transl)].
    Arahata K; Sato T; Narabayashi H
    Rinsho Shinkeigaku; 1981 Jul; 21(7):597-606. PubMed ID: 7307400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autoimmunity in myasthenia gravis].
    Kawanami S; Mori R; Kuroiwa Y
    Nihon Rinsho; 1973 Feb; 31(2):300-4. PubMed ID: 4737109
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocytotoxins in myasthenia gravis.
    Knapp W; Pateisky K
    Z Immunitatsforsch Exp Klin Immunol; 1972 Dec; 144(4):329-34. PubMed ID: 4283252
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological studies in myasthenia gravis.
    Rose JW; Huang SW; Mayer RF
    Trans Am Neurol Assoc; 1975; 100():60-3. PubMed ID: 1084071
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of lymphocytes E rosette-formation rate in cerebrospinal fluid and peripheral blood (author's transl)].
    Zhang YH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Nov; 14(4):238-41. PubMed ID: 7343236
    [No Abstract]   [Full Text] [Related]  

  • 10. Auto-immune aspects of myasthenia gravis.
    Downes JM; Greenwood BM; Wray SH
    Q J Med; 1966 Jan; 35(137):85-105. PubMed ID: 5296438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies to striated muscle in myasthenia gravis, demonstration of specific reactivity of F (ab')2-piece (author's transl)].
    Knapp W; Pateisky K
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jun; 143(5):477-82. PubMed ID: 4282930
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microviscosity and lipid composition of lymphocytes from myasthenia gravis and systemic lupus erythematosus (author's transl)].
    Hiramatsu K; Arimori S
    Rinsho Ketsueki; 1981 Aug; 22(8):1237-40. PubMed ID: 7328777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological study in patients with myasthenia gravis (author's transl)].
    Monden Y; Masaoka A; Maeda M; Nakahara K; Oshima S; Hirose H; Matsuyama M; Tani Y; Seike Y; Nakata S; Nakaoka K; Tanioka T; Kagotani K; Nishikawa H
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Nov; 26(11):1369-74. PubMed ID: 731076
    [No Abstract]   [Full Text] [Related]  

  • 14. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report.
    Pirskanen R; Tiilikainen A; Hokkanen E
    Ann Clin Res; 1972 Oct; 4(5):304-6. PubMed ID: 4644453
    [No Abstract]   [Full Text] [Related]  

  • 16. [A longitudinal study of immunological parameters in multiple sclerosis (author's transl)].
    Simon J; Mar P; Neu I; Kamm S; Schrader A
    Nervenarzt; 1980 Mar; 51(3):176-82. PubMed ID: 7453878
    [No Abstract]   [Full Text] [Related]  

  • 17. [The correlation between autoantibodies and leukocyte migration index in myasthenia gravis (author's transl)].
    Chiu HC; Chen RC; Hung TP; Deng JS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):129-34. PubMed ID: 7285665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymectomy and muscle antibodies in myasthenia gravis].
    Romi F; Gilhus NE; Aarli JA
    Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HL-A typing and autoantibodies in patients with myasthenia gravis].
    Feltkamp TE; van den Berg-Loonen PN; Engelfriet CP; Nijenhuis LE; van Rossum AL; van Lochem JJ; Oosterjuis HJ
    Ned Tijdschr Geneeskd; 1974 Jun; 118(23):895-6. PubMed ID: 4839444
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical analysis of 113 cases of myasthenia gravis (author's transl)].
    Cong ZQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):29-31. PubMed ID: 7307785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.